Mon, Sep 1, 2014, 3:55 PM EDT - U.S. Markets closed for Labor Day

Recent

% | $
Quotes you view appear here for quick access.

MannKind Corp. Message Board

  • cooieppi cooieppi Oct 7, 2013 3:04 PM Flag

    Cover . NOW

    News soon, partnership. Novo shunned and they put out a press release saying they will make the Pill form of Afrezza, that's because they have been told the winner and that their bid was too low. Go see Novo article today for yourself. It was a defensive move...

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Well I cannot find any recent Novo press release about their pill form of insulin. However I would not want Novo Nordisk as a partner due to their leadership in injected insulin products and clear conflict of interest in marketing Afrezza that would really hurt Novo's insulin products moat. Such a partnership would not work for MNKD.

 
MNKD
7.37+0.05(+0.68%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.